Nutritional supplement attenuates selected oxidative stress markers in pediatric patients with cystic fibrosis

Nutrition Research

Volumn 31, Issue 7, 2011, Pages 509-518

  Sadowska Woda, Izabela ^a   Rachel, Marta ^b   Pazdan, Joanna ^a   Bieszczad Bedrejczuk, Edyta ^a   Pawliszak, Katarzyna ^a  

^a UNIVERSITY OF RZESZÓW   (Poland)

^b Provincial Hospital Rzeszow   (Poland)

Author keywords

Antioxidants; AquADEKs; Cystic fibrosis; Human subject; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; AQUADEK; CATALASE; COLECALCIFEROL; DORNASE ALFA; FREE RADICAL; HYDROPEROXIDE; KREON; LIPANCREA; MALONALDEHYDE; MULTIVITAMIN; REACTIVE OXYGEN METABOLITE; RETINOL; SUPEROXIDE DISMUTASE; THIOL GROUP; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHEWABLE TABLET; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DRUG CAPSULE; DRUG DOSAGE FORM; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; SCHOOL CHILD;

ADOLESCENT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; DOSAGE FORMS; ERYTHROCYTES; HUMANS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; VITAMINS;

EID: 80051594020     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.07.002     Document Type: Article

References (57)

1. Cantin A.M., White T.B., Cross C.E., Forman H.J., Sokol R.J., Borowitz D. Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12. Free Radic Biol Med 2007 2003, 42:15-31.
2. Erdman S.H. Nutritional imperatives in cystic fibrosis therapy. Pediatr Ann 1999, 28:129-136.
3. Kalivianakis M., Minich D.M., Bijleveld C.M., van Aalderen W.M., Stellaard F., Laseur M., et al. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 1999, 69:127-134.
4. Sagel S.D., Sontag M.K., Anthony M.M., Emmett P., Papas K.A. Effect of an antioxidant-rich multivitamin supplement in cystic fibrosis. J Cyst Fibros 2011, 10:31-36.
5. Lagrange-Puget M., Durieu I., Ecochard R., Abbas-Chorfa F., Drai J., Steghens J.P., et al. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr Pulmonol 2004, 38:43-49.
6. Ntimbane T., Krishnamoorthy P., Huot C., Legault L., Jacob S.V., Brunet S., et al. Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children. J Cyst Fibros 2008, 7:373-384.
7. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., Collins C.E., Garg M.L. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001, 20:157-165.
8. Suzuki K. Nutritional management of cystic fibrosis. Arch Dis Child 1996, 74:81-87.
9. Linsdell P., Hanrahan J.W. Glutathione permeability of CFT. Am J Physiol 1998, 275:C323-C326.
10. Sadowska-Woda I., Popowicz D., Karowicz-Bilińska A. Bifenthrin-induce oxidative stress in human erythrocytes in vitro and protective effect of selected flavonols. Toxicol in Vitro 2010, 24:879-884.
11. Shiva Shankar Reddy C.S., Subramanyam M.V., Vani R., Asha Devi S. In vitro models of oxidative stress in rat erythrocytes: effect of antioxidant supplements. Toxicol in Vitro 2007, 21:1355-1364.
12. van Rossen M.E., Sluiter W., Bonthuis F., Jeekel H., Marquet R.L., van Eijck C.H. Scavenging of reactive oxygen species leads to diminished peritoneal tumor recurrence. Cancer Res 2000, 60:5625-5629.
13. McCord J.M. The evolution of free radicals and oxidative stress. Am J Med 2000, 108:652-659.
14. Góth L., Vitai M. The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocatalasemic patients. Free Radic Biol Med 2003, 35:882-888.
15. Cimen M.Y. Free radical metabolism in human erythrocytes. Clin Chim Acta 2008, 390:1-11.
16. Wood L.G., Gibson P.G., Garg M.L. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003, 2:177-186.
17. Ghiselli A., Serafini M., Natella F., Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000, 29:1106-1114.
18. Halliwell B. Reactive oxygen species in living systems: source, biochemistry and role in human disease. Am J Med 1991, 3C:14S-22S.
19. Xia J., Browning J.D., O'Dell B. Decreased plasma thiol concentration is associated with increased osmotic fragility of erythrocytes in zinc-deficient rats. J Nutr 1999, 129:814-819.
20. Papas K., Kalbfleisch J., Mohon R. Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Dig Dis Sci 2007, 52:347-352.
21. Kulaga Z., Litwin M., Tkaczyk M., Rózdzyńska A., Barwicka K., Grajda A., et al. The height-, weight-, and BMI-for-age of Polish school-aged children and adolescents relative to international and local growth references. BMC Public Health 2010, 4:10-109.
22. Andersen H.R., Nielsen J.B., Nielsen F., Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clin Chem 1997, 43:562-568.
23. Dodge J.T., Mitchell C., Hanahan D.J. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963, 100:119-130.
24. Blincoe C. The simultaneous separation and washing of erythrocytes. Clin Chim Acta 1974, 57:297-300.
25. Tsuchihashi M. Zur Kenntnis der Blutkatalase. Biochemische Zeitschrift 1923, 140:65-74.
26. Aebi H. Catalase in vitro. Meth Enzymol 1984, 105:121-126.
27. Marklund S.L., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pirogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
28. Bartosz G. Druga twarz tlenu. Wolne rodniki w przyrodzie 2004, 358-359. Warszawa, PWN.
29. Benzie I.F., Strain J.J. Ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem 1996, 239:70-76.
30. Gay C., Gebicki J.M. A critical evaluation of the effect of sorbitol on the ferric-xylenol orange hydroperoxide assay. Analy Biochem 2000, 284:217-220.
31. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
32. Rice C.A., Diplock A.T., Symons M.C.R. Techniques in Free Radical Research 1991, Vol. 22:19-50. Elsevier, New York. K.H. Bundon, P.H. Kuippenberg (Eds.).
33. Dominguez C., Gartner S., Liñán S., Cobos N., Moreno A. Enhanced oxidative damage in cystic fibrosis patients. Biofactors 1998, 8:149-153.
34. Madarasi A., Lugassi A., Greiner E., Holics K., Biró L., Mozsáry E. Antioxidant status in patients with cystic fibrosis. Ann Nutr Metab 2000, 44:207-211.
35. Lepage G., Champagne J., Ronco N., Lamarre A., Osberg I., Sokol R.J., et al. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1996, 68:87-93.
36. Rust P., Eichler I., Renner S., Elmadfa I. Effects of long term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis. Int J Vitaminol Nutr Res 1998, 68:83-87.
37. Hagar H.H. Folic acid and vitamin B(12) supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats. Pharmacol Res 2002, 46:213-219.
38. Joshi R., Adhikari S., Patro B.S., Chattopadhyay S., Mukherjee T. Free radical scavenging behaviour of folic acid evidence for possible antioxidant activity. Free Radic Biol Med 2001, 30:1390-1399.
39. Roum J.H., Buhl R., McElvaney N.G., Borok Z., Crystal R.G. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 1993, 75:2419-2424.
40. Range S.P., Dunster C., Knox A.J., Kelly F.J. Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status. Eur Respir J 1999, 13:560-564.
41. Langley S.C., Brown R.K., Kelly F.J. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr Res 1993, 33:247-250.
42. Wood L.G., Gibson P.G., Garg M.L. Circulating markers to assess nutritional therapy in cystic fibrosis. Clin Chim Acta 2005, 353:13-29.
43. Guyrkovits K., Szabo L., Laslo A., Matkovics B. Comparative study of superoxide dismutase, catalase and lipid peroxidation from cystic fibrosis patients. Monographs in pediatrics 1981, Vol 14:56-144. European. Working. Group for Cystic Fibrosis, Bern, Switzerland. F. Falkner, N. Kretchmer, E. Rossi (Eds.).
44. Matkovics B., Gyurkovits K., László A., Szabó L. Altered peroxide metabolism in erythrocytes from children with cystic fibrosis. Clin Chim Acta 1982, 125:59-62.
45. Laskowska-Klita T., Chełchowska M. Antioxidant status in erythrocytes of cystic fibrosis children. Acta Biochim Pol 2001, 48:283-285.
46. Willison H.J., Muller D.P., Matthews S., Jones S., Kriss A., Stead R.J., et al. A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. J Neurol Neurosurg Psychiatry 1985, 48:1097-1102.
47. Percival S.S., Bowser E., Wagner M. Reduced copper enzyme activities in blood cells of children with cystic fibrosis. Am J Clin Nutr 1995, 62:633-638.
48. Castillo R., Landon C., Eckhardt K. Selenium and vitamin E status in cystic fibrosis. J Pediatr 1981, 99:583-585.
49. Portal B.C., Richard M.J., Faure H.S., Hadjian A.J., Favier A.E. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995, 61:843-847.
50. Alda J.O., Garay R. Chloride (or bicarbonate)-dependent copper uptake through the anion exchanger in human red blood cells. Am J Physiol 1990, 259:C570-C576.
51. Kwon H.Y., Choi S.Y., Won M.H., Kang T., Kang J.H. Oxidative modification and inactivation of Cu,Zn-superoxide dismutase by 2,2'-azobis(2-amidinopropane) dihydrochloride. Biochim Biophys Acta 2000, 1543:69-76.
52. Suzuki K. Anti-oxidants for therapeutic use: why are only a few drugs in clinical use?. Adv Drug Deliv Rev 2009, 61:287-289.
53. Solomons N.W., Romero-Abal M.E., Weiss G., Michalke B., Schumann K. Bioavailability of zinc from NutriSet zinc tablets compared with aqueous zinc sulfate. Eur J Clin Nutr 2011, 65:125-131.
54. Tran C.D., Miller L.V., Krebs N.F., Lei S., Hambidge K.M. Zinc absorption as a function of the dose of zinc sulfate in aqueous solution. Am J Clin Nutr 2004, 80:1570-1573.
55. Carmagnol F., Sinet P.M., Lenoir G., Nicole A., Rapin J., Jérome H. Absence of modifications of the enzyme defense system against oxygen toxicity in cystic fibrosis. Pediatr Res 1983, 17:181-182.
56. Brown R.K., Wyatt H., Price J.F., Kelly F.J. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996, 9:334-339.
57. Lands L.C., Grey V.L., Grenier C. Total plasma antioxidant capacity in cystic fibrosis. Pediatr Pulmonol 2000, 29:81-87.